Filter
304
Text search:
mRNA
Featured
56
8
Language
Document type
99
64
38
32
29
11
11
8
5
3
2
1
1
Countries / Regions
23
16
12
10
8
7
7
6
4
4
4
4
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
92
15
8
7
4
3
1
Toolboxes
198
22
9
6
5
4
4
4
3
3
3
2
1
1
1
1
1
21 January 2022
The overall threat posed by Omicron largely depends on four key questions: (i) how transmissible the variant is; (ii) how well vaccines and prior infection protect against infection, transmission, clinical disease and death; (iii) how virulent the variant is compared to other varian
...
22 Sept. 2021
The rapid development of effective Covid-19 vaccines in 2020 gave hope to the world in the darkest days of the deadly pandemic. However, the vaccine roll-out has been massively skewed towards wealthy nations. While rich states have hoarded vaccines, companies have also played a decisi
...
This article is part four in a series of explainers on vaccine development and distribution.
Part one focused on how vaccines work to protect our bodies from disease-carrying germs.
Part two focused on the ingredients in a vaccine and the three clinical trial phases.
Part three focused on the ste
...
These are standing orders for eligible nurses and healthcare professionals to administer the Moderna COVID-19 vaccine to persons 18 years of age and older
COVID-19 vaccination: supply and logistics guidance: interim guidance, 12 February 2021 (Arabic Version)
recommended
12 February 2021
A Organização Mundial da Saúde (OMS), com apoio do Grupo Consultivo Estratégico de Especialistas em Imunização (Strategic Advisory Group of Experts on Immunization – SAGE) e do respectivo Grupo de Trabalho para Vacinas contra a COVID-19, está analisando novas evidências sobre o uso de vaci
...
11 august 2022, updated version
Here are resources to help accredited continuing education (CE) providers develop and deliver education about the COVID-19 vaccines. If you have any questions about accreditation requirements or any aspect of accredited education related to these vaccines
As of January 20, 2021 the Covid-19 - living NMA initiative collected 150 RCTs and 36 non-randomised studies of vaccines from the ICTRP. 93 of these trials are recruiting patients.
Will COVID-19 vaccines be safe? Will all the COVID-19 candidate vaccines be successful? What are the different phases a vaccine must go through to be approved? This document provides responses to the most frequently asked questions about candidate vaccines and access to COVID-19 vaccination.
Impfung & COVID-19
recommended
MEDBOX Issue Brief no. 7, Dec. 2020
Die Impfung gegen die Ausbreitung des SARS-CoV-2-Virus stellt einen Meilenstein in der Bekämpfung der Pandemie dar. Für den Erfolg der Impfung unabdingbar ist eine gute Kommunikation und Aufklärung der Bevölkerung. Im Folgenden sind einige Informationen zur I
...
This bi-weekly brief details the latest developments in scientific knowledge and public health policy from around the world as well as updates to the COVID-19-related guidance from Africa CDC, WHO and other public health agencies.
31 March 2021
This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explained series.
Countries around the world are rolling ou
...
Published:February 02, 2021DOI:https://doi.org/10.1016/S0140-6736(21)00234-8
Vaccine hesitancy
recommended
April 19,2021
MEDBOX Issue Brief no.12
